Abstract Background Patients with locally advanced or recurrent rectal cancer often require multimodality treatment. Intraoperative radiation therapy (IORT) is a focal approach which aims to improve local control. Methods We retrospectively reviewed 42 patients treated with IORT following definitive resection of a locally advanced or recurrent rectal cancer from 2000–2009. All patients were treated with the Intrabeam® Photon Radiosurgery System (PRS). A dose of 5 Gy was prescribed to a depth of 1 cm (surface dose range: 13.4-23.1, median: 14.4 Gy). Median survival times were calculated using Kaplan-Meier analysis. Results Of 42 patients, 32 had recurrent disease (76%) while 10 had locally advanced disease (24%). Eighteen patients (43%) had ...
Carcinoma of the rectum is a heterogeneous disease. The clinical spectrum identifies a subset of pat...
Simple Summary Although relatively rare, locally advanced or recurrent rectal cancer (LARC and LRRC)...
BACKGROUND: Local recurrence after rectal cancer treatment occurs in approximately 5% to 10% of pati...
Recurrent rectal or rectosigmoid cancer is a difficult therapeutic problem. A treatment program of e...
Purpose: The aim of this study was to evaluate the effect of high-dose-rate intraoperative radiation...
Multimodal strategies have been implemented for locally recurrent rectal cancer scheduled for comple...
PURPOSE: Treatment protocols for patients with locally recurrent rectal cancer have changed in the l...
Abstract Background Patients with recurrent retroperitoneal and pelvic region tumors often require m...
Risk of local recurrence of rectal cancer remains high despite extensive therapeutic strategies, man...
According to the results of several studies intraoperative radiotherapy seems to influence local con...
PURPOSE: Intraoperative radiation therapy (IORT) is advocated by some for patients with locally adva...
PURPOSE: This study was designed to analyze the results of a multimodality treatment using preoperat...
Object: The use of aggressive multimodality treatment including preoperative chemo-radiation, surger...
Objective: Aim of this study is analysing the pooled results of Intra-Operative Electron beam Radiot...
ObjectiveWe sought to evaluate the effectiveness and safety of utilizing radiotherapy (RT) with stan...
Carcinoma of the rectum is a heterogeneous disease. The clinical spectrum identifies a subset of pat...
Simple Summary Although relatively rare, locally advanced or recurrent rectal cancer (LARC and LRRC)...
BACKGROUND: Local recurrence after rectal cancer treatment occurs in approximately 5% to 10% of pati...
Recurrent rectal or rectosigmoid cancer is a difficult therapeutic problem. A treatment program of e...
Purpose: The aim of this study was to evaluate the effect of high-dose-rate intraoperative radiation...
Multimodal strategies have been implemented for locally recurrent rectal cancer scheduled for comple...
PURPOSE: Treatment protocols for patients with locally recurrent rectal cancer have changed in the l...
Abstract Background Patients with recurrent retroperitoneal and pelvic region tumors often require m...
Risk of local recurrence of rectal cancer remains high despite extensive therapeutic strategies, man...
According to the results of several studies intraoperative radiotherapy seems to influence local con...
PURPOSE: Intraoperative radiation therapy (IORT) is advocated by some for patients with locally adva...
PURPOSE: This study was designed to analyze the results of a multimodality treatment using preoperat...
Object: The use of aggressive multimodality treatment including preoperative chemo-radiation, surger...
Objective: Aim of this study is analysing the pooled results of Intra-Operative Electron beam Radiot...
ObjectiveWe sought to evaluate the effectiveness and safety of utilizing radiotherapy (RT) with stan...
Carcinoma of the rectum is a heterogeneous disease. The clinical spectrum identifies a subset of pat...
Simple Summary Although relatively rare, locally advanced or recurrent rectal cancer (LARC and LRRC)...
BACKGROUND: Local recurrence after rectal cancer treatment occurs in approximately 5% to 10% of pati...